Literature DB >> 9033281

Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas.

M L Larramendy1, M Tarkkanen, J Valle, A H Kivioja, H Ervasti, E Karaharju, T Salmivalli, I Elomaa, S Knuutila.   

Abstract

Comparative genomic hybridization was used to search for previously unknown gains and losses of DNA sequences along all chromosome arms in 29 chondrosarcoma specimens obtained from 23 patients. Extensive genetic aberrations, with a mean of 6 changes per tumor (range, 1 to 24), were detected in 21 of the 29 samples analyzed (72%). The majority of these changes were gains of whole chromosomes or whole chromosome arms. Gains of DNA sequence copy number were most frequent at 20q (38%), 17p (38%), 20p (31%), 1cen-q24 (28%), and 14q23-qter (28%). High-level amplifications of small chromosome regions were sporadic, detected in only 17% of the samples. The only recurrent high-level amplification, seen in two tumors (7%), affected the minimal common region 12cen-q15. Other amplifications, each encountered only once, involved 1p33-p35, 2p23-pter, 4p, 6p22-pter, 18q12-q22, 19p13.2, 19q13.2, and 20q13.1. Losses of DNA sequences were rare and were most commonly observed at 6cen-q22 (17%) and 9p (17%).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033281      PMCID: PMC1858280     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  R-banding and nonisotopic in situ hybridization: precise localization of the human type II collagen gene (COL2A1).

Authors:  E Takahashi; T Hori; P O'Connell; M Leppert; R White
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

2.  The gene for the alpha 2 chain of the human fibrillar collagen type XI (COL11A2) assigned to the short arm of chromosome 6.

Authors:  M L Law; S D Chan; R Berger; C Jones; F T Kao; E Solomon; K S Cheah
Journal:  Ann Hum Genet       Date:  1990-01       Impact factor: 1.670

3.  Chromosomal rearrangements in chondromatous tumors.

Authors:  N Mandahl; S Heim; K Arheden; A Rydholm; H Willén; F Mitelman
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

4.  Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11.

Authors:  Y Q Wu; P Heutink; B B de Vries; L A Sandkuijl; A M van den Ouweland; M F Niermeijer; H Galjaard; E Reyniers; P J Willems; D J Halley
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

5.  Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas.

Authors:  A Forus; D O Weghuis; D Smeets; O Fodstad; O Myklebost; A Geurts van Kessel
Journal:  Genes Chromosomes Cancer       Date:  1995-09       Impact factor: 5.006

6.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11.

Authors:  W H Raskind; E U Conrad; H Chansky; M Matsushita
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

8.  Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization.

Authors:  A Kallioniemi; O P Kallioniemi; G Citro; G Sauter; S DeVries; R Kerschmann; P Caroll; F Waldman
Journal:  Genes Chromosomes Cancer       Date:  1995-03       Impact factor: 5.006

9.  Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization.

Authors:  M Tarkkanen; R Karhu; A Kallioniemi; I Elomaa; A H Kivioja; J Nevalainen; T Böhling; E Karaharju; E Hyytinen; S Knuutila
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

Review 10.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

Authors:  O P Kallioniemi; A Kallioniemi; J Piper; J Isola; F M Waldman; J W Gray; D Pinkel
Journal:  Genes Chromosomes Cancer       Date:  1994-08       Impact factor: 5.006

View more
  13 in total

Review 1.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

2.  Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.

Authors:  M L Larramendy; M Tarkkanen; C Blomqvist; M Virolainen; T Wiklund; S Asko-Seljavaara; I Elomaa; S Knuutila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha.

Authors:  Ashish Lal; Tomoko Kawai; Xiaoling Yang; Krystyna Mazan-Mamczarz; Myriam Gorospe
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

Review 4.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

Review 5.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

6.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.

Authors:  J R Bischoff; L Anderson; Y Zhu; K Mossie; L Ng; B Souza; B Schryver; P Flanagan; F Clairvoyant; C Ginther; C S Chan; M Novotny; D J Slamon; G D Plowman
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

7.  DNA copy number changes in development and progression in leiomyosarcomas of soft tissues.

Authors:  W El-Rifai; M Sarlomo-Rikala; S Knuutila; M Miettinen
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

8.  Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.

Authors:  Silvia Calabuig-Fariñas; Rosario Gil Benso; Karoly Szuhai; Isidro Machado; José Antonio López-Guerrero; Danielle de Jong; Amando Peydró; Teresa San Miguel; Lara Navarro; Antonio Pellín; Antonio Llombart-Bosch
Journal:  Pathol Oncol Res       Date:  2012-02-15       Impact factor: 3.201

9.  Treatment of Bone Tumors.

Authors:  Rajiv Rajani; C Parker Gibbs
Journal:  Surg Pathol Clin       Date:  2012-03

10.  Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.

Authors:  Andrew J Evans; Brenda L Gallie; Michael A S Jewett; Gregory R Pond; Kirk Vandezande; John Underwood; Yves Fradet; Gloria Lim; Paula Marrano; Maria Zielenska; Jeremy A Squire
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.